AMT provides Additive Manufacturing capabilities to medical technology centre
October 17, 2018
AMT PTE LTD, Singapore, will offer its Additive Manufacturing capabilities to support Accuron MedTech Group’s new $10 million technology centre in Tuas, Singapore. Accuron MedTech is said to be the largest medical device maker in Southeast Asia, and its new 2050 m2 (22,000 ft2) technology centre will provide incubator facilities and business services for its portfolio companies which are complementary to its core urology business.
The new facility is located near to the global headquarters of AMT, which has stated that it will provide Accuron Medtech’s companies access to its advanced manufacturing capabilities, including Additive Manufacturing, clean-room manufacturing and assembly and medical device sterilisation. It will also offer critical commercialisation support resources such as R&D, finance, HR and business development.
Beh Kian Teik, Assistang Managing Director of Singapore Economic Development Board, stated, “The technology centre is an important undertaking that brings together the deep engineering and design capabilities of a large corporate such as Accuron MedTech, with the agility of start-ups to enable the development of new solutions for regional and global healthcare needs from Singapore.”
Renal company AWAK Technologies was the first portfolio company to move its headquarters to the new centre. As a development stage company, it has access to the centre’s clean room manufacturing and assembly facility to support its research, development, manufacturing and commercial activities. As more companies move to the technology centre, the company stated that there is potential to expand the available space by 50%.
